regeneron glp-1 gip treatment muscle loss side effects Pharmaceuticals announced on January 30, 2026, that its experimental obesity drug candidate delivers significant cholesterol-lowering benefits on top of weight loss—a differentiation strategy aimed at competing with Eli Lilly's and Novo Mitigating loss of lean muscle

Researchers became interested when early trials demonstrated unprecedented efficacy in metabolic controlwith some studies showing nearly 30% of subjects achieving normoglycemia and over 20% average weight losseffects that suggested the dual incretin approach might unlock mechanisms beyond what single-target agonists could achieve

He uses smart glasses with a microphone and a camera to ask what room hes in as he learns to live without sight

The treatment can also improve kidney function, lower the risk of cardiovascular events like heart attacks and strokes, and enhance blood sugar regulation

Glucagon-like-peptide-2 (GLP-2) is a similar compound that is typically not considered an incretin due to its lack of glycemic effects